REVERSED-ROLE CHEMOTHERAPY FOR RESISTANT CANCER
- 1 October 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8510) , 778-781
- https://doi.org/10.1016/s0140-6736(86)90301-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A method to measure the duration of DNA syntheses and the potential doubling time from a single sampleCytometry, 1985
- Rapid fluorometric detection of drug resistant tumour cellsBritish Journal of Cancer, 1985
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- Amplification of Dihydrofolate Reductase Genes in Methotrexate-resistant Cultured Mouse CellsCold Spring Harbor Symposia on Quantitative Biology, 1978
- Genetic implication of karyological instability of malignant somatic cellsPhysiological Reviews, 1971
- Therapeutic effects of hydroxyurea.Experience with 118 patients with inoperable solid tumorsCancer, 1970
- 5-Iodo-2′-deoxyuridine and DNA synthesis in mammalian cellsExperimental Cell Research, 1968
- Deletion of thymidine kinase activity from L cells resistant to bromodeoxyuridineExperimental Cell Research, 1963
- Suppression of Infections Resulting from a Deoxyribonucleic Acid Virus (Vaccinia) By Systemic Administration of 5-Iodo-2′-DeoxyuridineNature, 1963
- Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidineBiochemical Pharmacology, 1960